The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ... Renal & Urology News: Packaging Error Prompts Recall of Enoxaparin Sodium Injection Patients exposed to a higher dose may be subject to bleeding complications.

Understanding the Context

Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ... (RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ... FiercePharma: Sandoz completes US offering of generic Lovenox® line with launch of enoxaparin sodium injection, USP vials Princeton, New Jersey, – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ... Sandoz completes US offering of generic Lovenox® line with launch of enoxaparin sodium injection, USP vials Yahoo Finance: Sandoz Canada launches its 6th biosimilar with Inclunox® and Inclunox® HP (Enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (High Potency)) Sandoz Canada launches its 6th biosimilar with Inclunox® and Inclunox® HP (Enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (High Potency)) Business Wire: Meitheal Pharmaceuticals Announces Launch of Enoxaparin Sodium Injection, USP in the United States CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc.

Key Insights

(“Meitheal”), a fully integrated generic injectables company today announced the launch of Enoxaparin Sodium Injection, USP, the generic ... Meitheal Pharmaceuticals Announces Launch of Enoxaparin Sodium Injection, USP in the United States The FDA has approved Amphastar Pharmaceuticals' Abbreviated New Drug Application (“ANDA”) for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial (MDV). The Company plans to launch ... Silver Spring, MD - The US Food and Drug Administration (FDA) has granted approval of the first generic formulation of enoxaparin (Lovenox, Sanofi-Aventis) sodium injection, a low-molecular-weight ... NOTE TO EDITORS: In response to multiple questions about the product's indications, the press release was revised to clarify that Sandoz's enoxaparin soldium for injection was approved for all of the ...

Final Thoughts